News Image

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Provided By GlobeNewswire

Last update: Sep 10, 2024

Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response

LIFEHAB is a Randomized Controlled Trial in Norway Comparing Lumbar Interbody Fusion Surgery With Multidisciplinary Rehabilitation

Read more at globenewswire.com

ACLARION INC -CW27

NASDAQ:ACONW (12/1/2025, 8:00:00 PM)

0.0487

+0.01 (+21.75%)


ACLARION INC

NASDAQ:ACON (12/1/2025, 8:00:00 PM)

6.5

+0.24 (+3.83%)



Find more stocks in the Stock Screener

Follow ChartMill for more